BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38280407)

  • 21. Heat Shock Protein 90α-Dependent B-Cell-2-Associated Transcription Factor 1 Promotes Hepatocellular Carcinoma Proliferation by Regulating MYC Proto-Oncogene c-MYC mRNA Stability.
    Zhou X; Wen Y; Tian Y; He M; Ke X; Huang Z; He Y; Liu L; Scharf A; Lu M; Zhang G; Deng Y; Yan Y; Mayer MP; Chen X; Zou F
    Hepatology; 2019 Apr; 69(4):1564-1581. PubMed ID: 30015413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback.
    Liu S; Bu X; Kan A; Luo L; Xu Y; Chen H; Lin X; Lai Z; Wen D; Huang L; Shi M
    Cancer Lett; 2022 Mar; 528():16-30. PubMed ID: 34958891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5.
    Xia C; Sun Y; Li Y; Ma J; Shi J
    Sci Rep; 2022 May; 12(1):7826. PubMed ID: 35552451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR-138-5p and activation of AKT/mTOR signaling pathway.
    Huang G; Li L; Liang C; Yu F; Teng C; Pang Y; Wei T; Song J; Wang H; Liao X; Li Y; Yang J
    Pharmacol Res Perspect; 2021 Feb; 9(1):e00720. PubMed ID: 33565716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linc01559 Served as a Potential Oncogene and Promoted Resistance of Hepatocellular Carcinoma to Oxaliplatin by Directly Sponging miR-6783-3p.
    Dong S; Fu Y; Yang K; Zhang X; Miao R; Long Y; Liu C
    Anticancer Agents Med Chem; 2021; 21(2):278-286. PubMed ID: 32698745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuated Salmonella carrying siRNA-CD24 improved the effect of oxaliplatin on HCC.
    Li B; Zhao T; Shao M; Cai J; Chen S; Chen X; Yang M; Zheng Y; Cui C; Guo S; Yang Z; Ren F; Jia H
    Int Immunopharmacol; 2023 Nov; 124(Pt B):111025. PubMed ID: 37827056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis.
    Li J; Qin X; Wu R; Wan L; Zhang L; Liu R
    J Cell Mol Med; 2020 May; 24(9):5152-5161. PubMed ID: 32222024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway.
    Mei J; Lin W; Li S; Tang Y; Ye Z; Lu L; Wen Y; Kan A; Zou J; Yu C; Wei W; Guo R
    J Exp Clin Cancer Res; 2022 Jan; 41(1):5. PubMed ID: 34980201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ ABCC1 axis.
    Hu H; Yang L; Li L; Zeng C
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2400-2406. PubMed ID: 29966655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC.
    Ma L; Xu A; Kang L; Cong R; Fan Z; Zhu X; Huo N; Liu W; Xue C; Ji Q; Li W; Chu Z; Kang X; Wang Y; Sun Z; Han Y; Liu H; Gao X; Han J; You H; Zhao C; Xu X
    Hepatology; 2021 Dec; 74(6):3213-3234. PubMed ID: 34322883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1.
    Li X; Lin Z; Zhang B; Guo L; Liu S; Li H; Zhang J; Ye Q
    Sci Rep; 2016 Feb; 6():21010. PubMed ID: 26867799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC.
    Kim MJ; Choi YK; Park SY; Jang SY; Lee JY; Ham HJ; Kim BG; Jeon HJ; Kim JH; Kim JG; Lee IK; Park KG
    Mol Cancer Res; 2017 Sep; 15(9):1230-1242. PubMed ID: 28584024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.
    You Y; Zheng Q; Dong Y; Xie X; Wang Y; Wu S; Zhang L; Wang Y; Xue T; Wang Z; Chen R; Wang Y; Cui J; Ren Z
    Oncotarget; 2016 May; 7(22):32221-31. PubMed ID: 27050147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma.
    Xiao J; Lv Y; Jin F; Liu Y; Ma Y; Xiong Y; Liu L; Zhang S; Sun Y; Tipoe GL; Hong A; Xing F; Wang X
    Cell Physiol Biochem; 2017; 43(5):1926-1938. PubMed ID: 29055955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma via Modulating the ATP1A1/CA2 Axis.
    Huang CJ; Zhang CY; Zhao YK; Wang D; Zhuang L; Qian L; Xie L; Zhu Y; Meng ZQ
    Am J Chin Med; 2023; 51(2):461-485. PubMed ID: 36655687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCN2-MAPK-Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma.
    Liao X; Bu Y; Jiang S; Chang F; Jia F; Xiao X; Song G; Zhang M; Ning P; Jia Q
    Hepatol Int; 2019 Jul; 13(4):440-453. PubMed ID: 31250351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.
    Xiu P; Dong X; Dong X; Xu Z; Zhu H; Liu F; Wei Z; Zhai B; Kanwar JR; Jiang H; Li J; Sun X
    Cancer Sci; 2013 Mar; 104(3):375-82. PubMed ID: 23279642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
    J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.